Medtronic CFO: No shift away from GPOs

Medtronic CFO Gary Ellis has explained to investors that the medical device maker isn't making a strategic shift away from group purchasing organizations, despite the recent cancellation of several contracts with Premier and Novation. "There's a lot of speculation around here that a strategic change is going on," Ellis told analysts at the Barclay's Capital Investors Conference in Miami. "That is not the case." News

Suggested Articles

Takeda tapped Roche’s Foundation Medicine to develop tissue- and blood-based companion diagnostic tests for its portfolio of lung cancer therapies.

Cellex has announced plans to develop a rapid coronavirus test that people can fully perform at home, from sample collection to result, using an app.

More than 20 states either don’t release or have incomplete data on the rapid antigen tests now considered key to containing the coronavirus.